CLDN10, a glandular epithelial marker in epithelial ovarian cancer (Seo et al., 2010), was reported to be a key immune-related gene in clear cell renal cell carcinoma (Yang et al., 2021) and papillary thyroid carcinoma (Xiang et al., 2020). Here, CLDN10 is linked to differentiated thyroid carcinoma.